| TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s disease P Chakrabarty, A Li, TB Ladd, MR Strickland, EJ Koller, JD Burgess, ... Journal of Experimental Medicine 215 (9), 2247-2264, 2018 | 56 | 2018 |
| Inflammatory pre-conditioning restricts the seeded induction of α-synuclein pathology in wild type mice EJ Koller, MMT Brooks, TE Golde, BI Giasson, P Chakrabarty Molecular neurodegeneration 12, 1-13, 2017 | 26 | 2017 |
| Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy EJ Koller, E Gonzalez De La Cruz, T Machula, KR Ibanez, WL Lin, ... Human molecular genetics 28 (19), 3255-3269, 2019 | 24 | 2019 |
| Ifngr1 and Stat1 mediated canonical Ifn-γ signaling drives nigrostriatal degeneration MR Strickland, EJ Koller, DZ Deng, C Ceballos-Diaz, TE Golde, ... Neurobiology of disease 110, 133-141, 2018 | 15 | 2018 |
| Tau-mediated dysregulation of neuroplasticity and glial plasticity EJ Koller, P Chakrabarty Frontiers in Molecular Neuroscience 13, 151, 2020 | 14 | 2020 |
| Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation EJ Koller, KR Ibanez, Q Vo, KN McFarland, E Gonzalez De La Cruz, ... Neuropathology and applied neurobiology 48 (2), e12779, 2022 | 11 | 2022 |
| Il-10 signaling reduces survival in mouse models of synucleinopathy SG Cockey, KN McFarland, EJ Koller, MMT Brooks, ... npj Parkinson's Disease 7 (1), 30, 2021 | 11 | 2021 |
| Intracerebral expression of AAV-APOE4 is not sufficient to alter tau burden in two distinct models of tauopathy EJ Koller, E Gonzalez De La Cruz, M Weinrich, T Williams, PE Cruz, ... Molecular neurobiology 57, 1986-2001, 2020 | 9 | 2020 |
| Gonzalez De La Cruz E EJ Koller Machula T, Ibanez KR, Lin WL, Williams T, Riffe CJ, Ryu D, Strang KH, Liu X …, 2019 | 8 | 2019 |
| Genetic deletion of PGF2α-FP receptor exacerbates brain injury following experimental intracerebral hemorrhage S Mohan, EJ Koller, JA Fazal, G De Oliveria, AI Pawlowicz, S Doré Frontiers in neuroscience 12, 340785, 2018 | 7 | 2018 |
| Temporal and spatially controlled APP transgene expression using Cre-dependent alleles EJ Koller, M Comstock, JC Bean, G Escobedo Jr, KW Park, JL Jankowsky Disease Models & Mechanisms 15 (5), dmm049330, 2022 | 4 | 2022 |
| Doxycycline for transgene control disrupts gut microbiome diversity without compromising acute neuroinflammatory response EJ Koller, CA Wood, Z Lai, E Borgenheimer, KL Hoffman, JL Jankowsky Journal of Neuroinflammation 21 (1), 11, 2024 | 1 | 2024 |
| Temporal and spatially controlled APP transgene expression using Cre-dependent alleles (vol 15, dmm049330, 2022) EJ Koller, M Comstock, JC Bean, G Escobedo Jr, KW Park, JL Jankowsky DISEASE MODELS & MECHANISMS 16 (3), 2023 | | 2023 |
| Correction: Temporal and spatially controlled APP transgene expression using Cre-dependent alleles EJ Koller, M Comstock, JC Bean, G Escobedo Jr, KW Park, JL Jankowsky Disease Models & Mechanisms 16 (3), dmm050136, 2023 | | 2023 |
| First person–Emily Koller E Koller Disease Models & Mechanisms 15 (5), 2022 | | 2022 |
